Browsing: completes

Mesoblast Limited MESO announced that it has completed patient treatment in a pivotal phase III MSB-DR004 study, evaluating its pipeline candidate, rexlemestrocel-L, for treating chronic low back pain (CLBP) caused by the inflammatory condition of degenerative disc disease

Aaron Donald continues to put in work with his former team. He has popped up on the NFL wire once again, with NFL.com’s Ian Rapoport indicating another Donald-Rams workout has taken place

Aug. 13, 2026 /PRNewswire/ — Diversified Data Processing & Consulting, Inc. (“DivDat”) is pleased to announce its acquisition of Meridian Integration. The acquisition expands DivDat’s ability to help healthcare providers, municipalities, utilities, and other organizations serve their customers by providing solutions to manage critical interactions with their customers

HONG KONG SAR – Media OutReach Newswire – 10 August 2026 – Faced with the dual challenges of a steady rise in chronic disease rates and the immense pressure borne by public health resources in Hong Kong, putting preventive healthcare into practice has become a matter of urgency. To actively respond to the Government’s direction…

BySoo Kim Newsweek is a Trust Project member See more of our trusted coverage when you search.to see more of our trusted coverage when you search.

Opus Genetics has completed patient enrollment in its registrational phase 3 clinical trial evaluating OPGx-LCA5, an investigational gene therapy for patients with LCA5-associated inherited retinal disease

|| View of SK Biotek’s Sejong plant, a subsidiary of SK Pharmteco. Photo courtesy of SK Pharmteco

DVIDS – Images – PCG BRP Gabriela Silang completes multinational maritime interdiction exercise during RIMPAC 2026 [Image 3 of 10]

This new CT Scanner at Marotta Family Hospital brings next-gen imaging technology closer to home for Niagara communities

This is a paid press release. Contact the press release distributor directly with any enquiries.